{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:18:59Z","timestamp":1790615939661,"version":"4.1.0"},"reference-count":72,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:00Z","timestamp":1790380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Palliat Med"],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Polypharmacy is increasingly common in the community, as is the risk of associated adverse outcomes. Decreasing the use of potentially inappropriate medications may be facilitated through deprescribing tools, although their effectiveness towards the end of life remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>To examine the psychometric properties of deprescribing tools and associated clinical outcomes in adults towards the end of life.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Systematic review without meta-analysis. Eligible studies described development and application of deprescribing tools for adults towards the end of life. The ROBINS-I V2 tool assessed risk of bias. The study was registered with PROSPERO (CRD420251018366).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources:<\/jats:title>\n                    <jats:p>MEDLINE, EMBASE, CINAHL, Scopus, Web of Science, Cochrane library, and grey literature were searched from 2000 until April 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Of 4108 papers, 34 studies met inclusion criteria. Eighteen deprescribing tools were identified. The Delphi method was most frequently used for item inclusion. Definitions of end of life varied. Thirteen studies assessed reliability and\/or validity; eight demonstrated reduction in the number of medicines. Clinical outcomes comparing deprescribing with control interventions were mostly non-significant, although supportive evidence existed for reduced mortality, reduced acute care referral and lower costs. Risk of bias was moderate to high.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>A range of deprescribing tools exist for patients towards the end of life. Deprescribing tools may reduce medication burden and improve outcomes, including mortality, acute care referral and medication costs. High risk of bias associated with these results limits strong conclusions regarding the validity and clinical impact of deprescribing tools used towards the end of life.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/02692163261483456","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:24:38Z","timestamp":1790418278000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Deprescribing tools in adults towards the end of life: A systematic review"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7693-3170","authenticated-orcid":false,"given":"Claire","family":"Meyerkort","sequence":"first","affiliation":[{"name":"Geriatrician Sir Charles Gairdner Osborne Park Health Care Group (SCGOPHCG), Perth, WA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4204-4551","authenticated-orcid":false,"given":"Emyr","family":"Rees","sequence":"additional","affiliation":[{"name":"Royal Perth Hospital, WA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2084-8469","authenticated-orcid":false,"given":"Amy","family":"Page","sequence":"additional","affiliation":[{"name":"Centre for Optimisation of Medicines, School of Health and Clinical Sciences, The University of Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8689-6199","authenticated-orcid":false,"given":"Osvaldo P.","family":"Almeida","sequence":"additional","affiliation":[{"name":"Institute for Health Research, University of Notre Dame Australia, Australia"},{"name":"Medical School, University of Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5148-0188","authenticated-orcid":false,"given":"Christopher","family":"Etherton-Beer","sequence":"additional","affiliation":[{"name":"WA Centre for Health and Ageing, University of Western Australia, Crawley, WA, Australia"},{"name":"Department of Rehabilitation and Geriatric Medicine, Royal Perth Hospital, WA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,9,26]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"crossref","unstructured":"Masumoto S Hosoi T Nakamura T et al. Polypharmacy and potentially inappropriate medications in patients with advanced cancer: prevalence and associated factors at the end of life. J Palliat Med 2024; 27: 749\u2013755. https:\/\/doi.org\/10.1089\/jpm.2023.0520","DOI":"10.1089\/jpm.2023.0520"},{"key":"e_1_3_4_3_2","doi-asserted-by":"crossref","unstructured":"Toh JJY Zhang H Soh YY et al. Prevalence and health outcomes of polypharmacy and hyperpolypharmacy in older adults with frailty: a systematic review and meta-analysis. Ageing Res Rev 2023; 83: 101811. https:\/\/doi.org\/10.1016\/j.arr.2022.101811","DOI":"10.1016\/j.arr.2022.101811"},{"key":"e_1_3_4_4_2","doi-asserted-by":"crossref","unstructured":"Vetrano DL Tosato M Colloca G et al. Polypharmacy in nursing home residents with severe cognitive impairment: results from the SHELTER study. Alzheimer Dement 2013; 9: 587\u2013593. https:\/\/doi.org\/10.1016\/j.jalz.2012.09.009","DOI":"10.1016\/j.jalz.2012.09.009"},{"key":"e_1_3_4_5_2","doi-asserted-by":"crossref","unstructured":"Scullion L Dodds H Liu Q et al. Medication use in the last year of life: a cross-sectional hospice study. BMJ Support Palliat Care 2022; 12: e740\u2013e743. https:\/\/doi.org\/10.1136\/bmjspcare-2019-002101","DOI":"10.1136\/bmjspcare-2019-002101"},{"key":"e_1_3_4_6_2","doi-asserted-by":"crossref","unstructured":"Wastesson JW Morin L Tan ECK et al. An update on the clinical consequences of polypharmacy in older adults: a narrative review. Expert Opin Drug Saf 2018; 17: 1185\u20131196. https:\/\/doi.org\/10.1080\/14740338.2018.1546841","DOI":"10.1080\/14740338.2018.1546841"},{"key":"e_1_3_4_7_2","doi-asserted-by":"crossref","unstructured":"Todd A Husband A Andrew I et al. Inappropriate prescribing of preventative medication in patients with life-limiting illness: a systematic review. BMJ Support Palliat Care 2017; 7: 113\u2013121. https:\/\/doi.org\/10.1136\/bmjspcare-2015-000941","DOI":"10.1136\/bmjspcare-2015-000941"},{"key":"e_1_3_4_8_2","doi-asserted-by":"crossref","unstructured":"Leelakanok N Holcombe AL Lund BC et al. Association between polypharmacy and death: a systematic review and meta-analysis. J Am Pharm Assoc 2017; 57: 729\u2013738.e10. https:\/\/doi.org\/10.1016\/j.japh.2017.06.002","DOI":"10.1016\/j.japh.2017.06.002"},{"key":"e_1_3_4_9_2","doi-asserted-by":"crossref","unstructured":"Fried TR O'Leary J Towle V et al. Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review. J Am Geriatr Soc 2014; 62: 2261\u20132272. https:\/\/doi.org\/10.1111\/jgs.13153","DOI":"10.1111\/jgs.13153"},{"key":"e_1_3_4_10_2","doi-asserted-by":"crossref","unstructured":"Maher RL Hanlon J Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf 2014; 13: 57\u201365. https:\/\/doi.org\/10.1517\/14740338.2013.827660","DOI":"10.1517\/14740338.2013.827660"},{"key":"e_1_3_4_11_2","doi-asserted-by":"crossref","unstructured":"Guti\u00e9rrez-Valencia M Izquierdo M Cesari M et al. The relationship between frailty and polypharmacy in older people: a systematic review. Br J Clin Pharmacol 2018; 84: 1432\u20131444. https:\/\/doi.org\/10.1111\/bcp.13590","DOI":"10.1111\/bcp.13590"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/jppr.1361"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12975"},{"key":"e_1_3_4_14_2","doi-asserted-by":"crossref","unstructured":"Thillainadesan J Gnjidic D Green S et al. Impact of deprescribing interventions in older hospitalised patients on prescribing and clinical outcomes: a systematic review of randomised trials. Drugs Aging 2018; 35: 303\u2013319. https:\/\/doi.org\/10.1007\/s40266-018-0536-4","DOI":"10.1007\/s40266-018-0536-4"},{"key":"e_1_3_4_15_2","doi-asserted-by":"crossref","unstructured":"Quek HW Page A Lee K et al. The effect of deprescribing interventions on mortality and health outcomes in older people: an updated systematic review and meta-analysis. Br J Clin Pharmacol 2024; 90: 2409\u20132482. https:\/\/doi.org\/10.1111\/bcp.16200","DOI":"10.1111\/bcp.16200"},{"key":"e_1_3_4_16_2","doi-asserted-by":"crossref","unstructured":"Gnjidic D Le Couteur DG Kouladjian L et al. Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes. Clin Geriatr Med 2012; 28: 237\u2013253. https:\/\/doi.org\/10.1016\/j.cger.2012.01.006","DOI":"10.1016\/j.cger.2012.01.006"},{"key":"e_1_3_4_17_2","doi-asserted-by":"crossref","unstructured":"Anlay DZ Paque K Van Leeuwen E et al. Tools and guidelines to assess the appropriateness of medication and aid deprescribing: an umbrella review. Br J Clin Pharmacol 2024; 90: 12\u2013106. https:\/\/doi.org\/10.1111\/bcp.15906","DOI":"10.1111\/bcp.15906"},{"key":"e_1_3_4_18_2","doi-asserted-by":"crossref","unstructured":"de Andrade FK Nunes RPI Zanetti MOB et al. Validated medication deprescribing instruments for patients with palliative care needs: a systematic review. Farm Hosp 2024; 48: 83\u201389. https:\/\/doi.org\/10.1016\/j.farma.2023.08.004","DOI":"10.1016\/j.farma.2023.08.004"},{"key":"e_1_3_4_19_2","doi-asserted-by":"crossref","unstructured":"Shrestha S Poudel A Forough AS et al. A systematic review on methods for developing and validating deprescribing tools for older adults with limited life expectancy. Int J Pharm Pract 2023; 31: 3\u201314. https:\/\/doi.org\/10.1093\/ijpp\/riac094","DOI":"10.1093\/ijpp\/riac094"},{"key":"e_1_3_4_20_2","doi-asserted-by":"crossref","unstructured":"Thompson W Lundby C Graabaek T et al. Tools for deprescribing in frail older persons and those with limited life expectancy: a systematic review. J Am Geriatr Soc 2019; 67: 172\u2013180. https:\/\/doi.org\/10.1111\/jgs.15616","DOI":"10.1111\/jgs.15616"},{"key":"e_1_3_4_21_2","doi-asserted-by":"crossref","unstructured":"Page MJ McKenzie JE Bossuyt PM et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 74: 790\u2013799. https:\/\/doi.org\/10.1016\/j.rec.2021.07.010","DOI":"10.1016\/j.rec.2021.07.010"},{"key":"e_1_3_4_22_2","unstructured":"Gen aged care data: people leaving aged care https:\/\/www.gen-agedcaredata.gov.au\/topics\/people-leaving-aged-care#reasonsforleavingagedcare (2024 accessed 25 February 2025)."},{"key":"e_1_3_4_23_2","doi-asserted-by":"crossref","unstructured":"Humphrey GB Inacio MC Lang C et al. Estimating potential palliative care needs for residential aged care: a population-based retrospective cohort study. Australas J Ageing 2024; 43: 782\u2013791. https:\/\/doi.org\/10.1111\/ajag.13345","DOI":"10.1111\/ajag.13345"},{"key":"e_1_3_4_24_2","doi-asserted-by":"crossref","unstructured":"Gibson D. Corrigendum to: Who uses residential aged care now how has it changed and what does it mean for the future? Aust Health Rev 2020; 44: 983. https:\/\/doi.org\/10.1071\/AH20040_CO","DOI":"10.1071\/AH20040_CO"},{"key":"e_1_3_4_25_2","doi-asserted-by":"crossref","unstructured":"Javadzadeh D Karlson BW Alfredsson J et al. Clinical Frailty Scale score is a predictor of short- mid- and long-term mortality in critically ill older adults (\u2a7e\u200970 years) admitted to the emergency department: an observational study. BMC Geriatr 2024; 24: 852. https:\/\/doi.org\/10.1186\/s12877-024-05463-7","DOI":"10.1186\/s12877-024-05463-7"},{"key":"e_1_3_4_26_2","doi-asserted-by":"crossref","unstructured":"Reeve E. Deprescribing tools: a review of the types of tools available to aid deprescribing in clinical practice. J Pharm Pract Res 2020; 50: 98\u2013107. https:\/\/doi.org\/10.1002\/jppr.1626","DOI":"10.1002\/jppr.1626"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1177\/02692163261416281"},{"key":"e_1_3_4_28_2","unstructured":"Systematic reviews in health https:\/\/canberra.libguides.com\/systematic\/search (2023 accessed 24 February 2025)."},{"key":"e_1_3_4_29_2","unstructured":"Polyglot search translator https:\/\/polyglot.sr-accelerator.com\/ (2017 accessed 15 April 2025)."},{"key":"e_1_3_4_30_2","unstructured":"Covidence systematic review software www.covidence.org (2025 accessed 3 March 2025)."},{"key":"e_1_3_4_31_2","unstructured":"Systematic review guide https:\/\/monashhealth.libguides.com\/systematic_review\/home (2025 accessed 14 May 2026)."},{"key":"e_1_3_4_32_2","unstructured":"Sterne J Higgans J. The risk of bias in non-randomized studies \u2013 of interventions version 2 (ROBINS-I V2) assessment tool https:\/\/www.riskofbias.info\/welcome\/robins-i-v2 (2025 accessed 26 February 2025)."},{"key":"e_1_3_4_33_2","doi-asserted-by":"crossref","unstructured":"Curtin D Dukelow T James K et al. Deprescribing in multi-morbid older people with polypharmacy: agreement between STOPPFrail explicit criteria and gold standard deprescribing using 100 standardized clinical cases. Eur J Clin Pharmacol 2019; 75(3): 427\u2013432. https:\/\/doi.org\/10.1007\/s00228-018-2598-y","DOI":"10.1007\/s00228-018-2598-y"},{"key":"e_1_3_4_34_2","doi-asserted-by":"crossref","unstructured":"Lavan AH Gallagher P O'Mahony D. Inter-rater reliability of STOPPFrail [Screening tool of older persons prescriptions in frail adults with limited life expectancy] criteria amongst 12 physicians. Eur J Clin Pharmacol 2018; 74: 331\u2013338. https:\/\/doi.org\/10.1007\/s00228-017-2376-2","DOI":"10.1007\/s00228-017-2376-2"},{"key":"e_1_3_4_35_2","doi-asserted-by":"crossref","unstructured":"Lindsay J Dooley M Martin J et al. The development and evaluation of an oncological palliative care deprescribing guideline: the \u2018OncPal deprescribing guideline\u2019. Support Care Cancer 2015; 23: 71\u201378. https:\/\/doi.org\/10.1007\/s00520-014-2322-0","DOI":"10.1007\/s00520-014-2322-0"},{"key":"e_1_3_4_36_2","doi-asserted-by":"crossref","unstructured":"McNeill R Hanger HC Chieng J et al. Polypharmacy in palliative care: two deprescribing tools compared with a clinical review. J Palliat Med 2021; 24(5): 661\u2013667. https:\/\/doi.org\/10.1089\/jpm.2020.0225","DOI":"10.1089\/jpm.2020.0225"},{"key":"e_1_3_4_37_2","doi-asserted-by":"crossref","unstructured":"Page AT Etherton-Beer CD Clifford RM et al. Deprescribing in frail older people\u2013do doctors and pharmacists agree? Res Soc Adm Pharm 2016; 12: 438\u2013449. https:\/\/doi.org\/10.1016\/j.sapharm.2015.08.011","DOI":"10.1016\/j.sapharm.2015.08.011"},{"key":"e_1_3_4_38_2","doi-asserted-by":"crossref","unstructured":"Heinrich CH McCarthy S McHugh S et al. Identification of potentially inappropriate medications in frail older adults residing in long-term care: a retrospective chart review study. Drugs Real World Outcomes 2023; 10: 97\u2013106. https:\/\/doi.org\/10.1007\/s40801-022-00342-2","DOI":"10.1007\/s40801-022-00342-2"},{"key":"e_1_3_4_39_2","doi-asserted-by":"crossref","unstructured":"MakkiII Cook HK Bartell N et al. Implementation of a standardized palliative care pharmacist deprescribing assessment. J Palliat Med 2025; 28: 617\u2013623. https:\/\/doi.org\/10.1089\/jpm.2024.0215","DOI":"10.1089\/jpm.2024.0215"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-019-05234-w"},{"key":"e_1_3_4_41_2","doi-asserted-by":"crossref","unstructured":"Chess-Williams LM Broadbent AM Hattingh L. Cross-sectional study to evaluate patients\u2019 medication management with a new model of care: incorporating a pharmacist into a community specialist palliative care telehealth service. BMC Palliat Care 2024; 23: 172. https:\/\/doi.org\/10.1186\/s12904-024-01508-1","DOI":"10.1186\/s12904-024-01508-1"},{"key":"e_1_3_4_42_2","doi-asserted-by":"crossref","unstructured":"van Merendonk LN Peters BJM M\u00f6hlmann JE et al. The potential for deprescribing in a palliative oncology patient population: a cross-sectional study. Eur J Hosp Pharm 2024; 31(1): 10\u201315. https:\/\/doi.org\/10.1136\/ejhpharm-2021-003143","DOI":"10.1136\/ejhpharm-2021-003143"},{"issue":"6","key":"e_1_3_4_43_2","first-page":"430","article-title":"The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people","volume":"9","author":"Garfinkel D","year":"2007","unstructured":"Garfinkel D, Zur-Gil S, Ben-Israel J. The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people. Isr Med Assoc J 2007; 9(6): 430\u2013434.","journal-title":"Isr Med Assoc J"},{"key":"e_1_3_4_44_2","doi-asserted-by":"crossref","unstructured":"Hurley E Dalton K Byrne S et al. Pharmacist-led deprescribing using STOPPFrail for frail older adults in nursing homes. J Am Med Dir Assoc 2024; 25: 105122. https:\/\/doi.org\/10.1016\/j.jamda.2024.105122","DOI":"10.1016\/j.jamda.2024.105122"},{"key":"e_1_3_4_45_2","doi-asserted-by":"crossref","unstructured":"Sakran R Litvak M Haim N et al. Deprescribing in hospitalized patients with cancer: a clinical pharmacist-initiated multidisciplinary intervention. J Oncol Pharm Pract 2026; 32: 490\u2013497. https:\/\/doi.org\/10.1177\/10781552241294016","DOI":"10.1177\/10781552241294016"},{"key":"e_1_3_4_46_2","doi-asserted-by":"crossref","unstructured":"Hurley E Byrne S Walsh E et al. Cost avoidance of pharmacist-led deprescribing using STOPPFrail for older adults in nursing homes. Int J Clin Pharm 2024; 46: 1163\u20131171. https:\/\/doi.org\/10.1007\/s11096-024-01749-3","DOI":"10.1007\/s11096-024-01749-3"},{"key":"e_1_3_4_47_2","doi-asserted-by":"crossref","unstructured":"Loo CW Ma BH-M. Reduction of polypharmacy in frail older patients in Hong Kong using STOPPFrail criteria. J Am Med Dir Assoc 2023; 24: 1261\u20131262.e15. https:\/\/doi.org\/10.1016\/j.jamda.2023.05.019","DOI":"10.1016\/j.jamda.2023.05.019"},{"key":"e_1_3_4_48_2","doi-asserted-by":"crossref","unstructured":"Whitty R Koo E Porter S et al. C08-A a pilot study of a MEdication RAtionalization (MERA) intervention. J Pain Symptom Manag 2016; 52(6): e25. https:\/\/doi.org\/10.1016\/j.jpainsymman.2016.10.042","DOI":"10.1016\/j.jpainsymman.2016.10.042"},{"key":"e_1_3_4_49_2","doi-asserted-by":"crossref","unstructured":"Curtin D Jennings E Daunt R et al. Deprescribing in older people approaching end of life: a randomized controlled trial using STOPPFrail criteria. J Am Geriatr Soc 2020; 68(4): 762\u2013769. https:\/\/doi.org\/10.1111\/jgs.16278","DOI":"10.1111\/jgs.16278"},{"key":"e_1_3_4_50_2","doi-asserted-by":"crossref","unstructured":"Okafor CE Keramat SA Comans T et al. Cost-consequence analysis of deprescribing to optimize health outcomes for frail older people: a within-trial analysis. J Am Med Dir Assoc 2024; 25: 539\u2013544.e2. https:\/\/doi.org\/10.1016\/j.jamda.2023.12.016","DOI":"10.1016\/j.jamda.2023.12.016"},{"key":"e_1_3_4_51_2","doi-asserted-by":"crossref","unstructured":"Potter K Flicker L Page A et al. Deprescribing in frail older people: a randomised controlled trial. PLoS One 2016; 11: e0149984. https:\/\/doi.org\/10.1371\/journal.pone.0149984","DOI":"10.1371\/journal.pone.0149984"},{"key":"e_1_3_4_52_2","doi-asserted-by":"crossref","unstructured":"Quek HW Etherton-Beer C Page A et al. Deprescribing for older people living in residential aged care facilities: pharmacist recommendations doctor acceptance and implementation. Arch Gerontol Geriatr 2023; 107: 104910. https:\/\/doi.org\/10.1016\/j.archger.2022.104910","DOI":"10.1016\/j.archger.2022.104910"},{"key":"e_1_3_4_53_2","doi-asserted-by":"crossref","unstructured":"Wouters H Scheper J Koning H et al. Discontinuing inappropriate medication use in nursing home residents: a cluster randomized controlled trial. Ann Intern Med 2017; 167(9): 609\u2013617. https:\/\/doi.org\/10.7326\/M16-2729","DOI":"10.7326\/M16-2729"},{"key":"e_1_3_4_54_2","doi-asserted-by":"crossref","unstructured":"Curtin D Gallagher P O'Mahony D. Deprescribing in older people approaching end-of-life: development and validation of STOPPFrail version 2. Age Ageing 2021; 50(2): 465\u2013471. https:\/\/doi.org\/10.1093\/ageing\/afaa159","DOI":"10.1093\/ageing\/afaa159"},{"key":"e_1_3_4_55_2","doi-asserted-by":"crossref","unstructured":"Elsten EECM Pot IE Geijteman ECT et al. Recommendations for deprescribing of medication in the last phase of life: an international Delphi study. J Pain Symptom Manag 2024; 68(5): 443\u2013455.e2. https:\/\/doi.org\/10.1016\/j.jpainsymman.2024.07.029","DOI":"10.1016\/j.jpainsymman.2024.07.029"},{"key":"e_1_3_4_56_2","doi-asserted-by":"crossref","unstructured":"Holmes HM Sachs GA Shega JW et al. Integrating palliative medicine into the care of persons with advanced dementia: identifying appropriate medication use. J Am Geriatr Soc 2008; 56: 1306\u20131311. https:\/\/doi.org\/10.1111\/j.1532-5415.2008.01741.x","DOI":"10.1111\/j.1532-5415.2008.01741.x"},{"key":"e_1_3_4_57_2","doi-asserted-by":"crossref","unstructured":"Khodyakov D Ochoa A Olivieri-Mui BL et al. Screening tool of older person\u2019s prescriptions\/screening tools to alert doctors to right treatment medication criteria modified for US nursing home setting. J Am Geriatr Soc 2017; 65: 586\u2013591. https:\/\/doi.org\/10.1111\/jgs.14689","DOI":"10.1111\/jgs.14689"},{"key":"e_1_3_4_58_2","doi-asserted-by":"crossref","unstructured":"Lavan AH Gallagher P Parsons C et al. STOPPFrail (Screening tool of older persons prescriptions in frail adults with limited life expectancy): consensus validation. Age Ageing 2017; 46(4): 600\u2013607. https:\/\/doi.org\/10.1093\/ageing\/afx005","DOI":"10.1093\/ageing\/afx005"},{"key":"e_1_3_4_59_2","doi-asserted-by":"crossref","unstructured":"Nyborg G Straand J Klovning A et al. The Norwegian General Practice\u2013Nursing Home criteria (NORGEP-NH) for potentially inappropriate medication use: a web-based Delphi study. Scand J Prim Health Care 2015; 33: 134\u2013141. https:\/\/doi.org\/10.3109\/02813432.2015.1041833","DOI":"10.3109\/02813432.2015.1041833"},{"key":"e_1_3_4_60_2","doi-asserted-by":"crossref","unstructured":"Shrestha S Poudel A Steadman KJ et al. Deprescribing tool for older PeoPle with limited-life expectancy (De-TOPPLE) version 1: Development and validation using a modified Delphi technique. Basic Clin Pharmacol Toxicol 2024; 134(1): 15\u201327. https:\/\/doi.org\/10.1111\/bcpt.13907","DOI":"10.1111\/bcpt.13907"},{"key":"e_1_3_4_61_2","doi-asserted-by":"crossref","unstructured":"Low CE Sanchez Pellecer DE Santivasi WL et al. Deprescribing in hospice patients: discontinuing aspirin multivitamins and statins. Mayo Clin Proc Innov Qual Outcomes 2021; 5(4): 721\u2013726. https:\/\/doi.org\/10.1016\/j.mayocpiqo.2021.06.010","DOI":"10.1016\/j.mayocpiqo.2021.06.010"},{"key":"e_1_3_4_62_2","doi-asserted-by":"crossref","unstructured":"Poudel A Ballokova A Hubbard RE et al. Algorithm of medication review in frail older people: focus on minimizing the use of high-risk medications. Geriatr Gerontol Int 2016; 16: 1002\u20131013. https:\/\/doi.org\/10.1111\/ggi.12589","DOI":"10.1111\/ggi.12589"},{"key":"e_1_3_4_63_2","doi-asserted-by":"crossref","unstructured":"Strassl I Windhager A Machherndl-Spandl S et al. TOP-PIC: a new tool to optimize pharmacotherapy and reduce polypharmacy in patients with incurable cancer. J Cancer Res Clin Oncol 2023; 149(10): 7113\u20137123. https:\/\/doi.org\/10.1007\/s00432-023-04671-9","DOI":"10.1007\/s00432-023-04671-9"},{"key":"e_1_3_4_64_2","unstructured":"National Hospice and Palliative Care Organization (NHPCO). Hospice medication deprescribing toolkit [Internet]. Version 1.0. Alexandria (VA): NHPCO https:\/\/allianceforcareathome.org\/wp-content\/uploads\/NHPCO_Deprescribing_Toolkit.pdf (2020 accessed 28 April 2025)."},{"key":"e_1_3_4_65_2","doi-asserted-by":"crossref","unstructured":"Hardy JE Hilmer SN. Deprescribing in the last year of life. J Pharm Pract Res 2011; 41(2): 146\u2013151. https:\/\/doi.org\/10.1002\/j.2055-2335.2011.tb00684.x","DOI":"10.1002\/j.2055-2335.2011.tb00684.x"},{"key":"e_1_3_4_66_2","doi-asserted-by":"crossref","unstructured":"Vrijkorte E de Vries J Schaafsma R et al. Optimising pharmacotherapy in older cancer patients with polypharmacy. Eur J Cancer Care 2020; 29(1): e13185. https:\/\/doi.org\/10.1111\/ecc.13185","DOI":"10.1111\/ecc.13185"},{"key":"e_1_3_4_67_2","doi-asserted-by":"crossref","unstructured":"McAdam C O'Dwyer E Dalton K. Pharmacist-led deprescribing interventions for cancer patients in a specialist palliative care setting. Support Care Cancer 2025; 33(4): 321. https:\/\/doi.org\/10.1007\/s00520-025-09341-9","DOI":"10.1007\/s00520-025-09341-9"},{"key":"e_1_3_4_68_2","doi-asserted-by":"crossref","unstructured":"van Lummel EV Ietswaard L Zuithoff NP et al. The utility of the surprise question: A useful tool for identifying patients nearing the last phase of life? A systematic review and meta-analysis. Palliat Med 2022; 36: 1023\u20131046. https:\/\/doi.org\/10.1177\/02692163221099116","DOI":"10.1177\/02692163221099116"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.050626"},{"key":"e_1_3_4_70_2","doi-asserted-by":"crossref","unstructured":"Gwilliam B Keeley V Todd C et al. Development of prognosis in palliative care study (PiPS) predictor models to improve prognostication in advanced cancer: prospective cohort study. BMJ 2015; 5: 390\u2013398. https:\/\/doi.org\/10.1136\/bmjspcare-2012-d4020rep","DOI":"10.1136\/bmjspcare-2012-d4020rep"},{"key":"e_1_3_4_71_2","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-P\u00e9rez A Alfaro-Lara ER Sierra-Torres MI et al. Validation of the LESS-CHRON criteria: reliability study of a tool for deprescribing in patients with multimorbidity. Eur J Hosp Pharm 2019; 26: 334\u2013338. https:\/\/doi.org\/10.1136\/ejhpharm-2017-001476","DOI":"10.1136\/ejhpharm-2017-001476"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.3233\/EFI-180221"},{"key":"e_1_3_4_73_2","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-P\u00e9rez A Alfaro-Lara ER Albi\u00f1ana-Perez S et al. Novel tool for deprescribing in chronic patients with multimorbidity: list of evidence-based deprescribing for chronic patients criteria. Geriatr Gerontol Int 2017; 17: 2200\u20132207. https:\/\/doi.org\/10.1111\/ggi.13062","DOI":"10.1111\/ggi.13062"}],"container-title":["Palliative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02692163261483456","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/02692163261483456","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02692163261483456","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:49:44Z","timestamp":1790614184000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/02692163261483456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,26]]},"references-count":72,"alternative-id":["10.1177\/02692163261483456"],"URL":"https:\/\/doi.org\/10.1177\/02692163261483456","relation":{},"ISSN":["0269-2163","1477-030X"],"issn-type":[{"value":"0269-2163","type":"print"},{"value":"1477-030X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,26]]},"article-number":"02692163261483456"}}